Tricyclic Antidepressants in the Treatment of Children with Attention Deficit Disorder

STEVEN R. PLISZKA

doi:10.1097/00004583-198703000-00002

Tricyclic Antidepressants in the Treatment of Children with Attention Deficit Disorder

STEVEN R. PLISZKA

Psychiatry

Research output: Contribution to journal › Article › peer-review

59 Scopus citations

Abstract

The controversy over the use of imipramine and other tricyclics in the treatment of attention deficit disorder (ADD), is examined, and all available literature is critically reviewed. Although both stimulants and antidepressants ameliorate ADD symptoms, the bulk of the literature suggests that overall, stimulants are superior to imipramine in the treatment of ADD. There may, however, be a subgroup of children with ADD who respond better to imipramine, and this group may be one characterized by higher levels of anxiety or depression or both.

Original language	English (US)
Pages (from-to)	127-132
Number of pages	6
Journal	Journal of the American Academy of Child and Adolescent Psychiatry
Volume	26
Issue number	2
DOIs	https://doi.org/10.1097/00004583-198703000-00002
State	Published - Jan 1 1987

Keywords

attention deficit disorder
tricyclic antidepressants

ASJC Scopus subject areas

Developmental and Educational Psychology
Psychiatry and Mental health

Access to Document

10.1097/00004583-198703000-00002

Fingerprint Dive into the research topics of 'Tricyclic Antidepressants in the Treatment of Children with Attention Deficit Disorder'. Together they form a unique fingerprint.

Cite this

@article{06a6c25053ac4a93a6f8d1c0179c8a4f,

title = "Tricyclic Antidepressants in the Treatment of Children with Attention Deficit Disorder",

abstract = "The controversy over the use of imipramine and other tricyclics in the treatment of attention deficit disorder (ADD), is examined, and all available literature is critically reviewed. Although both stimulants and antidepressants ameliorate ADD symptoms, the bulk of the literature suggests that overall, stimulants are superior to imipramine in the treatment of ADD. There may, however, be a subgroup of children with ADD who respond better to imipramine, and this group may be one characterized by higher levels of anxiety or depression or both.",

keywords = "attention deficit disorder, tricyclic antidepressants",

author = "PLISZKA, {STEVEN R.}",

year = "1987",

month = jan,

day = "1",

doi = "10.1097/00004583-198703000-00002",

language = "English (US)",

volume = "26",

pages = "127--132",

journal = "Journal of the American Academy of Child and Adolescent Psychiatry",

issn = "0890-8567",

publisher = "Elsevier Limited",

number = "2",

}

TY - JOUR

T1 - Tricyclic Antidepressants in the Treatment of Children with Attention Deficit Disorder

AU - PLISZKA, STEVEN R.

PY - 1987/1/1

Y1 - 1987/1/1

N2 - The controversy over the use of imipramine and other tricyclics in the treatment of attention deficit disorder (ADD), is examined, and all available literature is critically reviewed. Although both stimulants and antidepressants ameliorate ADD symptoms, the bulk of the literature suggests that overall, stimulants are superior to imipramine in the treatment of ADD. There may, however, be a subgroup of children with ADD who respond better to imipramine, and this group may be one characterized by higher levels of anxiety or depression or both.

AB - The controversy over the use of imipramine and other tricyclics in the treatment of attention deficit disorder (ADD), is examined, and all available literature is critically reviewed. Although both stimulants and antidepressants ameliorate ADD symptoms, the bulk of the literature suggests that overall, stimulants are superior to imipramine in the treatment of ADD. There may, however, be a subgroup of children with ADD who respond better to imipramine, and this group may be one characterized by higher levels of anxiety or depression or both.

KW - attention deficit disorder

KW - tricyclic antidepressants

UR - http://www.scopus.com/inward/record.url?scp=0023093476&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0023093476&partnerID=8YFLogxK

U2 - 10.1097/00004583-198703000-00002

DO - 10.1097/00004583-198703000-00002

M3 - Article

C2 - 3584008

AN - SCOPUS:0023093476

VL - 26

SP - 127

EP - 132

JO - Journal of the American Academy of Child and Adolescent Psychiatry

JF - Journal of the American Academy of Child and Adolescent Psychiatry

SN - 0890-8567

IS - 2

ER -